Navigation Links
VTT and the MSI combine their unique competencies to a new Center for Bioengineering
Date:10/26/2011

The VTT Technical Research Centre of Finland and the Molecular Sciences Institute (MSI) have joined forces to establish a new research center in Berkeley, California. The opening took place in Berkeley on Oct. 25. The keynote speech was given by Dr. Sydney Brenner - Nobel prize-winner and founder of the Molecular Sciences Institute.

The new VTT/MSI Center for Bioengineering will focus on cutting edge quantitative biology to develop novel strategies for the improved production of bio-based chemicals and proteins in industrial microbes and novel quantitative tools for the detection of toxins, chemicals and biomarkers of disease.

The mission of the research center is to enable the quantitative prediction of the behavior of biological systems. VTT as a member organization of the new institute will provide its frontier knowhow on industrial biotechnology and technological needs for the basic molecular level research carried out at the institute. The aim of the center is to have a positive effect on human health and well-being in addition to the bioeconomy.

"The new center generates basic science which will strengthen VTT's offering in the field of industrial biotechnology", says Erkki KM Leppvuori, President & CEO of VTT. "Industrial biotechnology is of high quality at VTT and in Finland. This new opportunity for collaboration is an important bridge between the Californian and European academic as well as industrial network".


'/>"/>
Contact: Anne-Christine Ritschkoff
anne.christine.ritschkoff@vtt.fi
358-207-225-546
VTT Technical Research Centre of Finland
Source:Eurekalert

Page: 1

Related biology news :

1. Game-changing project combines anxiety therapy and video games
2. Laser, electric fields combined for new lab-on-chip technologies
3. Iowa State hybrid lab combines technologies to make biorenewable fuels and products
4. Researchers combine active proteins with material derived from fruit fly
5. Combined molecular study techniques reveal more about DNA proteins
6. Newborn screening increases survival outcome for patients with severe combined immunodeficiency
7. Global Leaders Combine Forces to Provide Identity Security Documents for INTERPOL
8. AOptix Technologies to Show Combined Biometric Face and Iris Capture System at Biometrics Consortium Conference
9. Reading food labels, combined with exercise, can lead to weight loss
10. Biology, computer science combine efforts to fight cancer
11. Duke, LabCorp combine forces to create the Biomarker Factory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2017)... Feb. 2, 2017   TapImmune, Inc. ... company specializing in the development of innovative peptide ... of cancer and metastatic disease, announced today it ... manufacturing of a second clinical lot of TPIV ... receptor alpha. The manufactured vaccine product will be ...
(Date:1/30/2017)... , Jan. 30, 2017   Invitae Corporation ... fastest growing genetic information companies, today announced that it ... results and provide 2017 guidance on Monday, February 13, ... call that day at 4:45 p.m. Eastern / 1:45 ... management team will briefly review financial results, guidance, and ...
(Date:1/24/2017)... , Jan. 24, 2017  It sounds simple ... sock that monitors vital signs and alerts parents ... infant,s oxygen saturation level drops. But pediatric experts ... to parents, with no evidence of medical benefits, ... are marketed aggressively to parents of healthy babies, ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... (PRWEB) , ... February 16, 2017 , ... Avomeen & ... The event will be held at Avomeen Analytical Services (4840 Venture Dr., Ann ... MichBio member organization. They provide an opportunity to interact with peers, make new connections ...
(Date:2/16/2017)... Calif. , Feb. 16, 2017  ArmaGen, ... developing groundbreaking therapies to treat severe neurological disorders, ... children treated with AGT-181, the company,s investigational therapy ... (also known as mucopolysaccharidosis type I, or MPS ... 2 proof-of-concept (POC) study, presented today at the ...
(Date:2/16/2017)... 16, 2017 Patient Care ... innovative telemedicine application, new and leading edge therapies ... a boom worldwide. The healthcare sector as whole ... services and new therapies for companies such as ... Cellectar Biosciences, Inc. (NASDAQ: CLRB ), ...
(Date:2/16/2017)... Malden, MA (PRWEB) , ... February 16, 2017 ... ... viscoelastic 4-level cervical case. Dr. Kingsley Chin, professor and Harvard trained surgeon, completed ... The procedure was performed on a 55-year-old practicing female physician suffering from degenerative ...
Breaking Biology Technology: